Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 38.0
(-0.26%)
ILA 38.0
(-0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 44.22 Million | 49.29 Million | 37.03 Million | 21.65 Million | - | - |
| Cost of Revenue | 45.98 Million | 52.83 Million | 50.09 Million | 22.37 Million | 1.07 Million | 362 Thousand |
| Gross Profit | -1.75 Million | -3.53 Million | -13.06 Million | -712 Thousand | -1.07 Million | -362 Thousand |
| Operating Expenses | 89.63 Million | 13 Million | 19.55 Million | 31.69 Million | 9.58 Million | 20.42 Million |
| Selling, General and Administrative Expenses | 8.48 Million | 3.05 Million | 2.95 Million | 7.48 Million | 6.15 Million | 593 Thousand |
| Research and Development Expenses | 3.89 Million | 5.15 Million | 7.19 Million | 2.15 Million | 634 Thousand | - |
| Other Expenses | 77.25 Million | 10.1 Million | 9.58 Million | -428 Thousand | - | - |
| Cost and Expenses | 135.61 Million | 65.83 Million | 69.64 Million | 54.06 Million | 10.65 Million | 20.78 Million |
| Operating Income | -91.39 Million | -49.38 Million | -32.75 Million | -33.88 Million | -9.94 Million | -19.34 Million |
| Interest Expense | 2.3 Million | 1.76 Million | 1.28 Million | 1.13 Million | 279 Thousand | 390 Thousand |
| Income Tax Expense | 25 Thousand | 12 Thousand | -1.21 Million | -273 Thousand | -747 Thousand | -1.6 Million |
| Earnings before Tax | -93.99 Million | -49.1 Million | -34.02 Million | -35.02 Million | -10.93 Million | -21.17 Million |
| Net Income | -88.88 Million | -48.23 Million | -32.65 Million | -32.94 Million | -10.88 Million | -21.17 Million |
| Earnings Per Share Basic | -1.41 | -0.95 | -0.73 | -0.90 | -0.56 | -2.82 |
| Earnings Per Share Diluted | -1.41 | -0.95 | -0.73 | -0.90 | -0.56 | -2.80 |
| Weighted Average Shares Outstanding | 63.01 Million | 50.79 Million | 44.74 Million | 36.41 Million | 19.53 Million | 7.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.01 Million | 50.79 Million | 44.74 Million | 36.41 Million | 19.53 Million | 7.56 Million |
| Gross Margin | -0.04 | -0.07 | -0.35 | -0.03 | - | - |
| EBIT Margin | -0.75 | 0.06 | -0.35 | -0.85 | - | - |
| Profit Margin | -2.01 | -0.98 | -0.88 | -1.52 | - | - |
| EBITDA | -32.98 Million | 4.83 Million | -13.04 Million | -19.89 Million | -9.94 Million | - |
| Earnings Before Tax Margin | -2.07 | -1.00 | -0.88 | -1.56 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 10.42 Million | 10.42 Million | 44.22 Million | 10.84 Million | 10.84 Million | 11.26 Million |
| Cost of Revenue | 9.78 Million | 9.78 Million | 45.98 Million | 9.65 Million | 9.65 Million | 6.69 Million |
| Gross Profit | 643 Thousand | 643 Thousand | -1.75 Million | 1.19 Million | 1.19 Million | 4.57 Million |
| Operating Expenses | 14.53 Million | 14.53 Million | 26.71 Million | -79.75 Million | 11.78 Million | 39.82 Million |
| Selling, General and Administrative Expenses | 4.51 Million | 4.51 Million | - | 4.87 Million | 4.87 Million | 6.54 Million |
| Research and Development Expenses | 343.5 Thousand | 343.5 Thousand | - | 399.5 Thousand | 399.5 Thousand | 1.54 Million |
| Other Expenses | 9.68 Million | 9.68 Million | -2.79 Million | -85.02 Million | - | - |
| Cost and Expenses | 24.31 Million | 24.31 Million | 72.7 Million | -70.1 Million | 21.43 Million | 46.52 Million |
| Operating Income | -13.89 Million | -13.89 Million | -91.39 Million | 80.95 Million | -11.54 Million | -35.06 Million |
| Interest Expense | - | - | 2.3 Million | - | - | 1.12 Million |
| Income Tax Expense | 1500.00 | 1500.00 | 25 Thousand | 12.5 Thousand | 12.5 Thousand | -3.73 Million |
| Earnings before Tax | -14.34 Million | -14.34 Million | -93.99 Million | -11.17 Million | -11.17 Million | -35.81 Million |
| Net Income | -14.34 Million | -14.34 Million | -88.88 Million | -10.68 Million | -10.68 Million | -33.76 Million |
| Earnings Per Share Basic | -0.29 | -0.29 | - | -0.17 | -0.17 | -0.55 |
| Earnings Per Share Diluted | -0.29 | -0.29 | - | -0.17 | -0.17 | -0.55 |
| Weighted Average Shares Outstanding | 50.32 Million | 50.32 Million | 63.01 Million | 64.65 Million | 64.65 Million | 61.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.32 Million | 50.32 Million | 63.01 Million | 64.65 Million | 64.65 Million | 61.38 Million |
| Gross Margin | 0.06 | 0.06 | -0.04 | 0.11 | 0.11 | 0.41 |
| EBIT Margin | -0.17 | -0.17 | - | -0.83 | -0.83 | -0.88 |
| Profit Margin | -1.38 | -1.38 | -2.01 | -0.98 | -0.98 | -3.00 |
| EBITDA | -1.76 Million | -1.76 Million | - | -9.03 Million | -9.03 Million | -9.88 Million |
| Earnings Before Tax Margin | -1.33 | -1.33 | -2.07 | 7.46 | -1.06 | -3.11 |
OPESF
002173
GJST
CONCORD
VBSN
JUBILE